Aditxt Inc (ADTX)

Aditxt Inc. is a pioneering biotechnology company focused on revolutionizing healthcare through its proprietary immune modulation and personalized medicine platform. The firm is committed to enhancing immune responses to tackle chronic diseases and allergies, thereby improving patient outcomes. With a promising pipeline of therapeutic candidates, strengthened by rigorous research and strategic partnerships, Aditxt is well-positioned to lead in the emerging sector of immune-based therapies. Emphasizing scientific innovation and patient-centric solutions, the company aims to make a significant impact on both immunology and the overall healthcare landscape.